Compare TCPC & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | TCPC | NBY |
|---|---|---|
| Founded | 2006 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.2M | 31.6M |
| IPO Year | 2006 | 2007 |
| Metric | TCPC | NBY |
|---|---|---|
| Price | $4.08 | $1.95 |
| Analyst Decision | Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 764.8K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | ★ 19.39% | N/A |
| EPS Growth | N/A | ★ 35.42 |
| EPS | N/A | ★ 0.76 |
| Revenue | N/A | ★ $370,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.57 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.43 | $0.43 |
| 52 Week High | $8.05 | $19.95 |
| Indicator | TCPC | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 60.45 | 57.82 |
| Support Level | $3.43 | $1.01 |
| Resistance Level | $5.99 | $2.52 |
| Average True Range (ATR) | 0.14 | 0.26 |
| MACD | 0.09 | 0.11 |
| Stochastic Oscillator | 96.27 | 96.45 |
BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.